GPS Wealth Strategies Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-61
Closed -$1K – 1156
2022
Q1
$1K Sell
61
-74
-55% -$1.56K ﹤0.01% 1005
2021
Q4
$5K Hold
135
– – ﹤0.01% 866
2021
Q3
$7K Hold
135
– – ﹤0.01% 783
2021
Q2
$6K Hold
135
– – ﹤0.01% 835
2021
Q1
$6K Buy
+135
New +$7.03K ﹤0.01% 751

Other funds holding NEO

GPS Wealth Strategies Group's NEO Position: Q2 2022 in Review

GPS Wealth Strategies Group sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 61 shares — an estimated $1K sold.

GPS Wealth Strategies Group first reported a position in NEO in Q1 2021 and held it in 5 quarters. The position peaked at $7K in Q3 2021. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • GPS Wealth Strategies Group reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 61 NeoGenomics shares in Q2 2022, an estimated $1K.
  • GPS Wealth Strategies Group first reported a position in NeoGenomics in Q1 2021 and held it in 5 quarters.
  • GPS Wealth Strategies Group's NeoGenomics position peaked at $7K in Q3 2021.
  • 239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on GPS Wealth Strategies Group's 13F filing for Q2 2022, filed 19 Jul 2022.